Security Snapshot

Ingevity Corp - Common Stock (NGVT) Institutional Ownership

CUSIP: 45688C107

13F Institutional Holders and Ownership History from Q2 2016 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

299

Shares (Excl. Options)

37,129,284

Price

$59.18

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / Common Stock
Symbol
NGVT on NYSE
Shares outstanding
35,236,027
Price per share
$71.23
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
37,129,284
Total reported value
$2,197,709,326
% of total 13F portfolios
0%
Share change
+722,360
Value change
+$45,044,286
Number of holders
299
Price from insider filings
$71.23
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • NGVT - Ingevity Corp - Common Stock is tracked under CUSIP 45688C107.
  • 299 institutions reported positions in Q4 2025.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 299 to 77 between Q4 2025 and Q1 2026.
  • Reported value moved from $2,197,709,326 to $75,114,814.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 299 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 45688C107?
CUSIP 45688C107 identifies NGVT - Ingevity Corp - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Ingevity Corp - Common Stock (NGVT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 16% $186,409,099 5,643,630 BlackRock, Inc. 31 Mar 2025
VANGUARD PORTFOLIO MANAGEMENT LLC 6.3% $157,409,902 2,209,879 Vanguard Portfolio Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.3% $132,018,750 1,853,415 Vanguard Capital Management 31 Mar 2026
VICTORY CAPITAL MANAGEMENT INC 2.2% $43,209,907 782,930 Victory Capital Management, Inc. 30 Sep 2025

As of 31 Dec 2025, 299 institutional investors reported holding 37,129,284 shares of Ingevity Corp - Common Stock (NGVT). This represents 105% of the company’s total 35,236,027 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Ingevity Corp - Common Stock (NGVT) together control 82% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 5,600,778 +1.8% 0.01% $331,454,039
VANGUARD GROUP INC 11% 4,024,906 -1.5% 0% $238,193,937
WELLINGTON MANAGEMENT GROUP LLP 5.4% 1,920,356 -5.3% 0.02% $113,646,668
AMERICAN CENTURY COMPANIES INC 4.3% 1,499,157 -2.4% 0.04% $88,720,111
STATE STREET CORP 4.1% 1,444,631 -2.7% 0% $85,493,263
SEGALL BRYANT & HAMILL, LLC 3.5% 1,218,345 -6.2% 0.98% $72,101,657
ROYCE & ASSOCIATES LP 3.2% 1,111,158 +7.7% 0.67% $65,758,330
BROWN ADVISORY INC 3% 1,040,944 +15% 0.09% $61,603,041
Simcoe Capital Management, LLC 2.9% 1,020,945 +9.4% 11% $60,419,525
MILLENNIUM MANAGEMENT LLC 2.6% 923,077 -22% 0.04% $54,627,697
VICTORY CAPITAL MANAGEMENT INC 2.5% 867,915 +7.4% 0.03% $51,363,210
GEODE CAPITAL MANAGEMENT, LLC 2.4% 841,157 -0.38% 0% $49,788,478
DIMENSIONAL FUND ADVISORS LP 2.2% 775,490 -2.6% 0.01% $45,893,303
FMR LLC 2% 693,071 +13% 0% $41,015,944
Maple Rock Capital Partners Inc. 1.9% 674,716 0% 1.3% $39,929,693
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.9% 666,952 -2.6% 0.01% $39,470,219
PRINCIPAL FINANCIAL GROUP INC 1.9% 652,237 +270% 0.02% $38,599,386
Harvey Partners, LLC 1.8% 629,430 +4.7% 3.3% $37,249,667
Boston Partners 1.8% 620,360 +142% 0.04% $36,718,922
PALISADE CAPITAL MANAGEMENT, LP 1.5% 529,585 -11% 0.93% $31,340,840
Vision One Management Partners, LP 1.3% 457,817 0% 15% $27,093,610
LONDON CO OF VIRGINIA 1.3% 448,770 -4.4% 0.15% $26,558,378
GOLDMAN SACHS GROUP INC 1.2% 424,038 +138% 0% $25,094,572
NORTHERN TRUST CORP 1.1% 388,238 -4.5% 0% $22,975,925
Pictet Asset Management Holding SA 1% 359,210 -4.6% 0.02% $21,258,048

Institutional Holders of Ingevity Corp - Common Stock (NGVT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 1,054,563 $75,114,814 -$7,693,572 $71.23 77
2025 Q4 37,129,284 $2,197,709,326 +$45,044,286 $59.18 299
2025 Q3 36,453,745 $2,011,852,730 -$34,792,943 $55.19 293
2025 Q2 37,101,809 $1,598,760,390 +$6,230,783 $43.09 265
2025 Q1 37,014,907 $1,465,215,049 +$16,983,774 $39.59 277
2024 Q4 36,587,963 $1,490,911,389 +$23,650,716 $40.75 252
2024 Q3 35,960,268 $1,402,789,725 +$41,342,231 $39.00 255
2024 Q2 34,597,622 $1,512,127,255 +$29,286,828 $43.71 262
2024 Q1 34,087,690 $1,625,932,221 -$19,651,264 $47.70 254
2023 Q4 34,523,207 $1,630,233,127 -$14,550,578 $47.22 248
2023 Q3 34,816,688 $1,657,365,226 -$59,477,359 $47.61 253
2023 Q2 35,728,300 $2,078,075,526 +$23,590,201 $58.16 244
2023 Q1 35,031,136 $2,505,360,522 +$41,546,725 $71.52 276
2022 Q4 34,619,047 $2,439,965,216 +$6,471,063 $70.44 288
2022 Q3 34,340,448 $2,082,929,615 -$44,686,452 $60.63 259
2022 Q2 34,792,810 $2,196,908,714 -$44,948,427 $63.14 249
2022 Q1 35,787,771 $2,292,845,208 -$47,419,416 $64.07 252
2021 Q4 36,310,882 $2,603,664,671 -$26,479,912 $71.70 255
2021 Q3 36,526,045 $2,606,854,475 -$28,656,860 $71.37 265
2021 Q2 36,847,530 $2,997,236,647 +$14,344,963 $81.36 261
2021 Q1 36,703,238 $2,771,618,072 -$27,444,301 $75.53 273
2020 Q4 37,119,873 $2,810,469,055 -$46,412,628 $75.73 269
2020 Q3 37,359,803 $1,846,931,574 -$39,387,839 $49.44 259
2020 Q2 38,098,376 $2,009,616,550 +$88,899,877 $52.57 270
2020 Q1 37,290,691 $1,312,782,191 -$182,579,009 $35.20 251
2019 Q4 39,115,389 $3,417,786,746 +$8,814,789 $87.38 319
2019 Q3 39,002,191 $3,309,036,014 +$9,530,355 $84.84 317
2019 Q2 38,813,600 $4,081,540,121 +$218,317,249 $105.17 322
2019 Q1 38,040,035 $4,018,027,836 -$133,373,276 $105.61 348
2018 Q4 39,322,861 $3,290,328,657 -$48,471,682 $83.69 298
2018 Q3 39,467,289 $4,020,222,346 +$7,331,451 $101.88 314
2018 Q2 39,482,213 $3,193,111,636 +$64,002,987 $80.86 289
2018 Q1 38,834,575 $2,861,924,154 -$1,790,990 $73.69 297
2017 Q4 38,914,682 $2,743,033,795 +$15,774,497 $70.47 301
2017 Q3 38,809,374 $2,425,120,683 +$11,936,135 $62.47 257
2017 Q2 38,674,698 $2,219,554,427 -$53,179,923 $57.40 238
2017 Q1 39,518,755 $2,404,735,520 +$315,892,061 $60.85 236
2016 Q4 39,224,486 $2,151,781,243 -$8,967,239 $54.86 249
2016 Q3 39,677,992 $1,827,090,148 +$68,942,167 $46.10 226
2016 Q2 39,910,285 $1,358,200,559 +$1,356,666,547 $34.04 223
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .